Article metrics

PDF
Letter
Follow-on rifaximin for the prevention of recurrence following standard treatment of infection with Clostridium difficile: a competing risks analysis provides a full picture of possible treatment effects

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: December 2018 to December 2018

AbstractFullPdf
Dec 20186762314
Total6762314